Barclays’s Beneficient BENF Stock Holding History

Barclays’s Portfolio BENF Stock Details BENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221	Buy	+60	New	+$209	﹤0.01%	5103
2025 Q2	–	Sell	-1	Closed	-$2	–	5264
2025 Q1	$2	Buy	+1	New	+$4	﹤0.01%	5211

Other funds holding BENF

YAG

Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.56B AUM 27.42% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Barclays's BENF Position: Q2 2026 in Review

Barclays opened a new position in Beneficient (BENF) in Q2 2026: 60 shares worth $221. The stake represents ﹤0.01% of the portfolio and ranks #5103 among its holdings. This is a return to the name: Barclays previously reported a position in BENF as recently as Q1 2025.

Barclays first reported a position in BENF in Q1 2025 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold BENF as of Q2 2026.

Barclays held 60 shares of Beneficient worth $221 as of Q2 2026.
Beneficient was a new Barclays position in Q2 2026.
Beneficient made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5103 holding.
Barclays first reported a position in Beneficient in Q1 2025 and has held it in 2 quarters since.
15 funds tracked by Wall St. Rank held Beneficient as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.